What's New in Research Funding

Molecular structuresPage last updated February 18, 2019

We are pleased to assist the research community in identifying potential sources of funding through the provision of information posted here:

  • All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal. This is an online submission process to obtain institutional approval on research applications. Please note that you will be required to upload a copy of the application to this online submission. Please complete this step as early as possible and at least several days ahead of the deadline to insure all approvals are obtained on time. Please visit the OVPRI's MRA webpage for complete information on this process.
  • Please note, all grants requiring the Dean's signature should be brought to the Faculty of Medicine Research Office in the Medical Sciences Building, Room 2331 to the attention of Cindy Faber cindy.faber@utoronto.ca.
  • Also, our office offers a grant editing service for researchers submitting proposals to tri-council or any other funding agency. For more information, please contact dan.harney@utoronto.ca.
  • Recently received news and updates are posted below and sent via email to our LISTSERV. To join click here.

Comprehensive funding opportunities may be searched through these links:

Recently Received News and Updates
 

February 18, 2019
 

  • Consultation: new Canadian Research and Development Classification. A national consultation to inform the development of the new Canadian Research and Development Classification (CRDC) was recently launched by the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), the Social Sciences and Humanities Research Council (SSHRC), the Canada Foundation for Innovation (CFI) and Statistics Canada.
    The CRDC will improve how research and development activities and investments are classified in Canada, and will allow greater harmonization, integration and coordination among Canada’s granting agencies.
    You are invited to share your views through the online consultation, which is open until March 22, 2019.
     
  • SickKids Foundation: New Investigator Research Grants.  This program provides support to child health researchers early in their careers so that they can compete with more senior investigators for research grants from other funders. Grant recipients may obtain up to three years of support for research in the biomedical, clinical, health systems and services, population and public health sectors. Amount: Up to $100,000 per year for up to 3 years. 
    Deadline for applications: April 22, 2019. 
    Community Conference Grants bring together families with researchers and clinicians for medical presentations, workshops, symposia and family-oriented discussions. The conference helps to ensure families receive access to the most up-to-date information regarding their children's health. The grant will support events which are organized by and/or for families with children with health challenges, including, but not limited to children with acute illness, chronic illness and disabilities. Amount: Up to $5,000 annually. Deadline for applications: May 31 or September 30, 2019.
     
  • Cancer Research Society: Translational Research Partnership Program. The goal of this program is to support collaborative and pivotal translational research projects. Amount: Up to a maximum of $1,500,000 over up to 3 years per project of which up to 50% may come from the Cancer Research Society. Projects must be translational research and may include clinical trial studies, aim the development of a therapeutic and/or novel technologies, and have excellent preliminary data to support the proposed project. There is no deadline associated with this program. Letters of Intent from applicants with high potential projects will be invited to submit an official application for funding, which is then peer-reviewed. 
     
  • Ontario Brain Institute: ONtrepreneurs Program. This program is Canada's single largest award that catalyzes early stage entrepreneurs to commercialize brain-related technologies by accessing funding and support to launch or grow their neurotechnology ventures. Preference will be given towards an applicant who recently graduated (less than 5 years from the last post-graduate fellowship). Amount: $50,000 (per individual) in addition to training opportunities and mentorship to help early-stage entrepreneurs to build and grow neurotech companies. Deadline for applications: April 1, 2019.
     
  • Cystic Fibrosis Foundation: Awards for Gene Editing for Cystic Fibrosis. To bring new technologies to the CF field, investigators without experience in CF research are encouraged to apply. Information about CF resources may be found in the Tools and Resources section.  The deadline for all applications is March 12, 2019. This RFA has four award options: 
  • Simons Foundation Autism Research Initiative: SFARI Summer 2019 Pilot Award. The goal of the Pilot Award is to provide early support for exploratory ideas, particularly those with novel hypotheses. Appropriate projects for this mechanism include those considered higher risk but with the potential for transformative results. To get a better understanding of SFARI’s different RFAs and whether the Pilot Award may be the best mechanism to support your project, please read their blog post “SFARI RFA reboot: Why, what and how". Amount: Up to USD $300,000 over a maximum of 2 years. Deadline for applications: April 18, 2019. 
     
  • The Orphan Disease Center and the Loulou Foundation: 2019 Pilot Grant Program for CDKL5 Deficiency Disorder (CDD). The Pilot Program provides a one‐year grant for USD $150,000.00 (total cost) to support research related to CDKL5 Deficiency Disorder (CDD). The number of awards may vary. See the RFA for priority areas. Deadline for Letters of Interest: March 8, 2019. Full application deadline: April 4, 2019.
     
  • United Mitochondrial Disease Foundation. UMDF Research Grants. The UMDF Trustees have identified training and supporting the mitochondrial disease research community as a priority for the current grant funding cycle. As such, awards will be made across a wide spectrum of career stages - from Postdoctoral Fellows to Young Investigators to Experienced Investigators. The Foundation's goal is to both aid in the development of the next generation of scientists dedicated to mitochondrial disease research as well as stimulating new directions for more senior researchers. Amounts vary per award. Deadline for proposals: March 15, 2019.
     
  • Human Frontiers Science Program Organization: Program and Young Investigator Grants. Teams will receive up to $450,000 per year for the whole team depending on the size of the team. You must initiate an application via the website by March 18th, 2019. Submission of the Letters of Intent deadline: March 28th, 2019.
    • Program Grants are awarded to teams of independent researchers at any stage of their careers. The research team is expected to develop new lines of research through the collaboration. Up to $450,000 per grant per year may be applied for. Applications including independent investigators early in their careers are encouraged.
    • Young Investigators' Grants are awarded to teams of researchers, all of whom are within the first five years after obtaining an independent laboratory (e.g. Assistant Professor, Lecturer or equivalent). Applications for Young Investigators' Grants will be reviewed in competition with each other independently of applications for Program Grants.
       
  • International Essential Tremor Foundation (IETF): Grant Program. The IETF is requesting proposals for grants addressing the nosology, etiology, pathogenesis, treatment or other topics relevant to essential tremor. Preference will be given to individuals who do not currently have any R01 support from NIH. Two proposals are being considered this year. Amount: Up to USD $25,000. Deadline for applications: February 28, 2019.
     
  • Ara Parseghian Medical Research Fund (Niemann-Pick Type C (NPC) disease): Research Grants. This funding supports an international research program:
    •To expedite a treatment and cure for NPC disease
    •To promote collaborative research efforts among the world’s leading experts in cholesterol metabolism, cell biology, neurobiology, genetics, pharmacology and other areas of science
    •To study similar and further the cause of other neurodegenerative diseases as well as cholesterol storage disorders
    Most grants are awarded up to USD $100,000 per year, but they are now offering competitive two-year grants as well. Deadline for Letters of Intent: March 1, 2019; Full application deadline: May 1, 2019.
     

  • Stiftelsen Promobilia Foundation: Grants for Research and Development Projects. The Foundation mainly gives support for development of tools for mobility handicapped but has also supported research about the comprehension of reading and writing difficulties. The Foundation has also supported research around diseases that could lead to severe motion problems. The Foundation gives grants in the range of SEK 100,000 - 500,000 (in USD about 10,000 - 100,000). Deadline for applications: March 14, 2019. 
     

February 5, 2019
 

  • 2019 NSERC Collaborative Research and Training Experience (CREATE):  Information Session.  NSERC’s CREATE program awards grants of up to $1.65M over 6 years for the development of innovative training programs that enhance collaboration and facilitate the transition of trainees to productive employees in the Canadian workforce.
    INFORMATION SESSION: Dr. Luis Seco, a former CREATE Committee member will give insights on the program and the application process. The session details are as follows:
    Tuesday February 12th, 2019, 10am – 11:30am
    McMurrich Building, 12 Queen’s Park Cres. West, Room 107.
    Please RSVP by February 8th by sending an email to:  Teresa Trimboli
    Internal deadlines: 
    • March 1, 2019: Internal Deadline to notify Jessica Keating of interest to apply.
    • April 1, 2019: Internal Deadline for completed Letters of Intent (Quota based).
       
  • Mitacs Globalink Research Award - Call for Applications. Up to 200 senior undergraduate and graduate student, as well as postdoctoral fellows from the university can participate in research exchanges through the Globalinks Research Award pathway. Faculty at U of T and an international university from a partner country will jointly supervise research projects. In addition, up to 80 students and postdoctoral fellows from international universities will come to Canada to conduct research at U of T. The funding for this international research mobility will allow students and researchers to build on their professional and academic networks, to refine their research skills in new environments and gain global fluency.
    Award amount: $6,000 Canadian for 12-24 week long research projects*
    Application deadline: 3 months prior to student arriving at host university
    Eligible participants: undergraduate and graduate Students, and postdoctoral fellows in all disciplines
    Application process: https://learningabroad.utoronto.ca/funding/gra/
    Contact: mahvish.wesley@utoronto.ca
     
  • AGE-WELL, Strategic Investment Program (SIP): Accelerator Funding. This funding program supports innovative post-discovery projects focused on the commercialization and/or knowledge mobilization of solutions (e.g. technologies, services or policies) aligned with AGE-WELL’s mission and vision. Amount: Up to $40,000 over 12 months. The program will also provide strategic mentorship and training opportunities from the AGE-WELL network and its partners in addition to financial support. Further details here. Deadline for Letters of Intent: March 1, 2019.
     
  • CIHR Team Grant - ERA-Net PerMed: Personalized Medicine: Multidisciplinary Research towards Implementation. This funding opportunity will support projects relevant to the following research areas, as described on the IC PerMed International Consortium website. Proposals are expected to include research on ethical, legal and socio-economic implications, including health economics and regulation, and/or research on optimisation of health care systems.
    Deadline for Pre-Proposal to ERA PerMed: March 7, 2019
    Full Proposal to ERA PerMed and Abbreviated Application to CIHR (201906ENP): June 17, 2019

     
  • Ontario Institute for Cancer Research: Cancer Therapeutics Innovation Pipeline.  This call for Letters of Intent (LOI) is for Late Accelerator projects. Focus on screening, using validated primary and secondary assays and to deliver confirmed Hit molecules against a defined target. Amount: Up to $250,000 per year for a maximum of two years. 
    LOI deadline: February 26, 2019; Response to LOI applicants: March 13, 2019
    Full application deadline: April 16, 2019
     
  • Cancer Research Society: 2019 Scholarships for the Next Generation of Scientists. This initiative aims at supporting future generations of Canadian researchers. The Scholarship is broken down into two parts, and extends over a period of 3 years, with no possibility for renewal. Deadline for submissions: April 26, 2019.
    • Part 1: Postdoctoral Salary Award -  1 year -  $50,000 (with a possibility of extending this award for a maximum period of 6 months)
    • Part 2: Operating Grant  -   2 years - $120,000 ($60,000/year)
       
  • Canadian Liver Foundation: Operating Grants. Operating Grants provide funding of up to $60,000 per year for a maximum of two years to hepatobiliary research investigators to pursue major research projects. As the CLF’s most senior award, it is offered to investigators with primary interest in hepatobiliary research who hold academic appointments in Canadian universities or affiliated institutions. Both clinical investigators and basic scientists will be considered. One operating grant may be awarded to a researcher in Canada whose research project is related to liver cancer, and another related to liver transplant. Deadline for applications: March 31, 2019.
     
  • The Ontario HIV Treatment Network (OHTN), Endgame Funding Program: Community-Based Research and Evaluation  (CBR&E) Awards. The objective of the CBR & E Funding is to assist communities by supporting the production and discovery of knowledge through community-based research; and the use of evidence to drive programming through participatory program evaluation. Amount: $25,000 - $50,000 for one year. Application deadlines: March 1, June 7, September 6 and December 6, 2019.
    OHTN's Strategic Plan to 2026: HIV Endgame.
     
  • Aplastic Anemia & MDS International Foundation, Inc. (AA&MDSIF): Research Grant Program. The Foundation is interested in funding research across the spectrum of basic and clinical science, but highest priority is for studies that have the potential to impact prevention, diagnosis, risk-stratification, or treatment of these diseases within three years. Preference will be given to New Investigators who propose a project that will contribute toward their professional development in bone marrow failure disease research. Amount: Up to USD $60,000 for two years. Deadline for Letters of Intent: February 15, 2019; Full application deadline: March 30, 2019.
     
  • Lupus Research Alliance: Distinguished Innovator Awards in Lupus. This Award provides outstanding scientists with substantial support to conduct novel research -- into the fundamental causes of systemic lupus erythematosus -- that can provide new directions towards a cure. The Lupus Research Alliance welcomes novel, hypothesis - or discovery - driven proposals in human and/or animal-model based lupus research. Amount: Up to USD $250,000 per year for up to four years. Deadline for Letters of Intent: March 15, 2019; Full application deadline: June 26, 2019.
     
  • Kenneth Rainin Foundation: Innovator Awards (in Inflammatory Bowel Disease). The Innovator Awards program provides grants for research projects, which due to their ground-breaking nature, may not be suitable for funding from more traditional sources, such as the National Institutes of Health (NIH). If an applicant is submitting a clinical research proposal, the Foundation encourages the applicant to include basic scientific methodologies to examine the underlying mechanisms of the proposed intervention/treatment. Amount: Up to USD $200,000. Deadline Letters of Inquiry: March 15, 2019; Deadline for full proposals: May 31, 2019.
     
  • International OCD Foundation.
    • Young Investigator Awards.  Research projects must investigate topics in the field of OCD and related disorders (OCD, including pediatric OCD; PANS/PANDAS; hoarding disorder; body dysmorphic disorder). Amount: Up to USD $50,000. Deadline for proposals: February 28, 2019.
    • Breakthrough and Innovator Awards (NEW). Eligible research projects must investigate topics in the field of OCD, with a focus on finding a cure for OCD. Note: this may include prevention (i.e., keeping OCD from taking hold), and treatment (i.e., once symptoms begin, can treatment reduce them as close as possible to zero). Innovator Awards - two awards of up to USD $300,000 each; Breakthrough Award - one award of up to USD $500,000. Deadline for proposals: February 28, 2019.
       

 

January 24, 2019
 

  • CIHR Project Grants - Spring 2019.  The Project Grant program will support a diverse portfolio of health-related research and knowledge translation projects at any stage, from discovery to application, including commercialization, and there will be a specific funding envelope to support new/early career investigators within the overall competition budget. Additional funds will also be made available through CIHR Institutes Priority Announcements to support Project Grant applications in specific research areas. 
    • More information specific to University of Toronto applicants, including Tips & Checklist documents for both Registration and Application submissions, is also available on the Research and Innovation website.
    • CIHR’s Learning For Applicants page provide an overview of the competition as well as a detailed tour of the application process and requirements.
    • CIHR informational webinars with question-and-answer portions will be held between January 23rd and February 27th. Full information on dates & times, as well as the opportunity to register for a webinar in advance, is available on CIHR’s webinars page.
    • Deadline for mandatory registration: February 6, 2019; Application deadline: March 6, 2019.
       
  • Genome Canada: Genomic Applications Partnership Program (GAPP) Round 15 & 16. Precision Health Initiative - Rare Diseases: Clinical Implementation Projects.  Genome Canada has launched a national initiative for the clinical implementation of precision health, focusing on a rare disease pilot program as a foundational step. In order to initiate this ambitious program, Genome Canada is encouraging the submission of projects to the GAPP. For more details, please see here. The GAPP funds public-private research collaborations focused on downstream research and development (R&D) projects that address real world opportunities and challenges defined by "Receptor" organizations such as industry, government, or not-for-profit entities. These organizations should be committed to commercializing or implementing the outcomes of the project. Applicants interested in applying are encouraged to contact Helen Petropoulos at Ontario Genomics (OG). For information on the application process, please visit the GAPP homepage, or the UofT funding opportunity
    Deadlines for Expressions of Interest (EOIs):
    • Round 15: Draft EOI is due to RSO and OG on Feb 19, 2019; Final EOIs are due to RSO April 1st via MRA to meet OG's deadline of April 8, 2019 
    • Round 16: Draft EOI is due to RSO and OG on May 20, 2019; Final EOIs are due to RSO July 2nd via MRA to meet OG's deadline of July 9, 2019 
       
  • CIHR Mental Wellness in Public Safety Team Grants. CIHR is launching this funding opportunity, to support the development of new research evidence and tools needed to address existing and emerging gaps in post-traumatic stress injuries (PTSI) as it relates to public safety personnel (PSP) in Canada. In alignment with the objectives and the research and strategic priorities of this funding opportunity, applicants are asked to integrate interdisciplinary, open science, and knowledge translation perspectives into their research. Additionally, applicants must integrate sex as a biological variable and/or gender as a social determinant of health. Deadline for Letter of Intent: March 19, 2019; Full application deadline: November 5, 2019.
     
  • REMINDER - Bloorview Research Institute: 2019 Pursuit Award. This prestigious award recognizes outstanding achievements in childhood disability research by PhD students across the globe. Every year, the Pursuit Award receives applications worldwide that are forward-thinking, innovative, and challenge the borders of childhood disability research. Eligibility: Current PhD students (no more than six months away from defence) and postdoctoral trainees/recent graduates (within one year of receiving their PhD) who have made significant contributions in applied or clinical childhood disability research. Any applied or clinical research specifically linked to childhood disability is eligible for consideration. Up to three monetary prizes are awarded and finalists may be eligible for a prestigious post-doctoral fellowship at the Bloorview Research Institute. View the Pursuits Submissions Call 2019. Deadline for applications: February 4, 2019 at 5pm EST.
     
  • Kidney Foundation of Canada (KFOC), ASF, Pedersen Family: Alport Syndrome Research Funding. Funding will be provided for basic science or clinical research on Alport Syndrome. These funds may be used as seed funding for the testing of initial hypotheses and the collection of preliminary data leading to successful long-term funding by NIH, CIHR, or other major funding institutions around the world. Early stage investigators are encouraged to apply. It is anticipated that two research projects will be selected for funding, totaling $100,000 each, over a one- to two-year timeframe. Deadline for applications: February 8, 2019. 
     
  • Physiotherapy Foundation of Canada: OrthoCanada Research Award in Neck and Back Rehabilitation and Core Stability. The award is seed funding for mainly pilot or feasibility projects. The award is for $20,000, jointly funded by OrthoCanada and the Physiotherapy Foundation of Canada (PFC). The principal investigator must be a member of the Canadian Physiotherapy Association. Deadline for applications: February 24, 2019.
     
  • Simons Foundation: Novel Outcome Measures in ASD Request for Applications. Grants awarded through this RFA will support the development and validation of clinically relevant outcome measures that will sensitively and reliably distinguish treatment effects from placebo response on the core symptoms of ASD (i.e., impairment in social communication and social interaction; restricted/repetitive behaviors, interests and activities; and sensory symptoms). The Foundation expects to fund several awards through this mechanism. The maximum budget is $300,000 USD per year, including indirect costs, for up to three years. Deadline for Notice of Intent: February 15, 2019; Application deadline: March 1, 2019.
     

 

January 15, 2019
 

  • Project Management Research Courses - UofT, Division of the Vice-President Research and Innovation (VPRI) and the School of Continuing Studies:  Project management - tailored for research - is an important skill that can reduce risk, delineate key project deliverables and increase the likelihood of research project success. This winter, the School of Continuing Studies is offering two courses in this area. Tuition Assistance: Please check the University’s web page for information on Educational Assistance Programs for Faculty and Staff regarding financial assistance for course tuition. 
    • 3382 Project Management for Research. This course was designed for faculty researchers, staff scientists, post-doctoral fellows, research coordinators and those interested in a path to management and research leadership. Information and registration can be found here for the Winter course starting January 15, 2019. The course will be in-class over 12 weeks. Each participant will have the opportunity to use their own research project in course exercises and assignments.
    • 3590 Six Simple Tools for Managing Research. This one-day seminar will be held March 1, 2019. It will be lead by Dr. Alison Paprica (PMP), Principal of Research Project Management, who does extensive consulting and training for the research sector. This interactive one-day workshop will provide practical tools to participants who will create their own planning documents during the workshop. Information and registration can be found here.
       
  • JLABS (Johnson & Johnson Innovation): QuickFire Challenge - Reimagining Respiratory Protection. JLABS is calling on innovators to revolutionize respiratory protection, to submit novel ideas to better protect against the inhalation of harmful infectious agents. Is there a household item that could transform into a lifesaving face mask during an emergency? Could new textiles or wearable technologies be incorporated into face masks to improve performance? Up to two innovators will be awarded up to $100,000 in grant funding, access to the JLABS ecosystem, and support in developing their ideas from BARDA, to support health security products and technologies in biotechnology, life science research, and medical innovations as they navigate research, development, and regulatory pathways. Deadline for applications: February 15, 2019.
     
  • NSERC Discovery Frontiers: Antimicrobial Resistance (AMR) in the Environment.  The objective this program on AMR is to support research that will integrate disciplines in new ways and provide new strategies and solutions at the forefront of this significant scientific challenge. Areas of importance include, but are not limited to: environmental sources and fate of antibiotic resistant microbes/genes, resistance ecology, resistance evolution, microbial community impacts, ecosystem impacts, impacts of AMR organisms on the environment, animal role as vectors, animal health risks, and mitigation options for further environmental AMR increase. Amount: Up to $1M per year for four years. Please contact jessica.keating@utoronto.ca with your intention to apply.
    UofT internal deadline for editorial review (LOI): February 6, 2019
    UofT Internal deadline for administrative review (LOI): February 21, 2019
    Sponsor deadline: March 1, 2019.

     
  • The Banting & Best Diabetes Centre:  Postdoctoral Fellowships. The BBDC will be awarding a number of postdoctoral fellowships to candidates at the post-PhD or post-MD degree stages.  The one-year fellowships normally commencing on July 1, 2019 (and no later than September 1, 2019) are for full-time research training in diabetes.  To be eligible, the candidate's proposed supervisor must be conducting diabetes research and must hold a faculty appointment with the University of Toronto at the level of Assistant, Associate, or Full Professor.  The proposed supervisor must be employed by the University of Toronto or a University of Toronto-affiliated institution, and must be a registered member of the BBDC at the time of application submission. Deadline for applications: February 26, 2019 at 4pm.
     
  • CIHR Joint Canada-Israel Health Research Program. The fifth call of this program supports biomedical sciences with special emphasis on new frontiers in metabolism in health and disease. Clinical Trials will NOT be funded through this funding opportunity. However, the use of randomization in basic biomedical research studies is accepted. The Program will support world-class research teams co-led by Canadian and Israeli investigators. The teams will be expected to integrate researchers from low- and middle-income countries to further their scientific capacity. Registration deadline: January 29, 2019; MRA deadline for UofT applicants: February 19, 2019; CIHR deadline in ResearchNet: February 26, 2019.
     
  • Autism Speaks: Funding Opportunities. 
    • Predoctoral Fellowships provides highly qualified candidates with exceptional research training opportunities broadly related to the study of autism spectrum disorder. Deadline for LOIs: February 27, 2019.
    • Postdoctoral Fellowships supports well-qualified postdoctoral scientists pursuing training in autism. Deadline for LOIs: February 27, 2019.
    • Adult Transition Research Grants aim to establish evidence-based scalable practices leading to improved postsecondary employment, education, community living and other key outcomes relevant to adolescents and young adults with ASD. Deadline for LOIs: March 13, 2019.
    • Database Analysis Grants invite novel grant applications to increase our basic understanding of autism — from genetics to behavior — by analyzing important databases generated by Autism Speaks: the Autism Genetics Research Exchange (AGRE) and/or MSSNG (a whole genome sequencing resource). Co-analysis of Autism Speaks datasets with other data is encouraged, along with proposals from early career investigators or investigators new to the field. Up to $100,000 for one year. Deadline for LOIs: March 6, 2019.
       
  • Epilepsy Foundation: New Therapy Commercialization Grant and Epilepsy Seal of Innovation Award. The Program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. The Program also encourages 1:1 matching grants to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. Preference will be given to proposals that already have a commercial partner engaged to assist with development, and to proposals that have committed or matched funding from a sponsoring institution, commercial partner or other third party source. Amount: Up to USD $350,000 for a maximum of two years. Deadline for Letters of Intent: January 28, 2019; Deadline for full proposals: April 1, 2019.
     
  • Jeffrey Modell Foundation: Translational Research Grants - (Primary Immunodeficiency). Grants with the following focus will be strongly considered for awards: 
    1. Novel PI defects 
    2. Innovativeness in early diagnosis 
    3. Treatment advances to a cure 
    4. Impact on patient health (i.e. how a patient will benefit) 
    5. Reach of the proposed project (i.e. how many patients might benefit) 
     Applications submitted by investigators with vast expertise in Primary Immunodeficiency, as well as young investigators with robust scientific merit will all be considered. All international and U.S. applicants are eligible. Upper amount: Up to USD $250,000 over a two-year period. Deadline for applications: February 15, 2019.
     
  • Prostate Cancer Foundation: 2019 Young Investigator Awards. Research proposals submitted in consideration for this award should, if successful, provide high impact to the field. “Small-step” or incremental proposals are usually non-competitive. Highly innovative basic science programs will be carefully considered, but priority will be given to “bench to bedside” translational research proposals with the potential to deliver near term benefit to patients. Amount: USD $75,000 per year for three years. Deadline for applications: March 18, 2019 at 3pm EST.
     
  • Cancer Research Institute: CFI Irvington Postdoctoral Fellowship Program. The CRI Irvington Fellowship furthers career development and supports laboratory research for promising young scientists working under the mentorship of leading immunologists. CRI accepts applications from qualified young scientists at leading universities and research centers around the world who wish to receive training in fundamental immunology or tumor immunology. The Institute is seeking hypothesis-driven, mechanistic studies in both immunology and tumor immunology that aim to directly impact our understanding of the immune system’s role in cancer. Amount: USD $175,500 over three years. Deadline for applications: April 1, 2019.
     
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.

January 9, 2019
 

  • New Frontiers in Research Fund - Exploration: Updates and Resources. Reminder about completing the NOI in order to apply at the Full Proposal stage: The NOI is a mandatory requirement and must be submitted by the NOI deadline of 8 pm EST January 11th, 2019.  Only those who submit an NOI on the Convergence system by the deadline will be able to complete a Full Proposal. 
    The Full Proposal remains under development and still on track to be available on January 14th, 2019.  Program staff indicated during the Webinars earlier this week that the short timelines of this call were being taken into account in the design of the Full Proposal format.
  • UPDATES: AGE-WELL Core Research Program (2020-2025) Call for Proposals - Multiple Revisions. Please note that there will now be three years of available funding through the Open Core Research Program Request for Proposals instead of the planned five. Milestones, deliverables, and budget should reflect a three-year project timeline highlighting what will be accomplished with AGE-WELL funds; however, applications outlining work initially planned for five years may still include the broader project scope. AGE-WELL will work with teams to position them for success through other funding sources for years 4-5. Letters of support from partners that reflect a five-year commitment do not need to be revised. Successful projects will be asked to update their partner commitments within the Catalyst Phase (April 2019 – March 2020). NEW DEADLINES: UofT internal deadline: January 15, 2019; Sponsor deadline: January 22, 2019.
     
  • Banting & Best Diabetes Centre (BBDC): Postdoctoral Fellowships: 2019/2020. The fellowships offered by the BBDC are in-training awards for individuals who hold (or are expecting to complete) a doctoral degree (PhD) or medical degree (MD). The objective of these awards is to attract and foster young investigators to initiate and/or continue research training in the field of diabetes. The one-year fellowships are to be used for full-time diabetes research training at the University of Toronto or one of its affiliated institutions. These awards become tenable July 1, 2019 (and no later than September 1, 2019). Deadline for applications: February 26, 2019 at 4pm.
     
  • Weston Brain Institute: Open Funding Opportunities.
    • Rapid Response Canada. Funding for transformative, novel, high-risk, high-reward translational research projects on neurodegenerative diseases of aging. Amount: Up to $300,000 over 18 months. 
      Parkinson's & Related Diseases: Program INFORMATION WEBINAR: January 31 at 1pm EST. Register here. Deadline for LOI's: March 13, 2019 at 2pm EST; Full Proposals deadline: July 16, 2019.
      Alzheimer's & Related Diseases: Program INFORMATION WEBINAR: February 27 at 1pm EST. Register here. Deadline for LOI's: April 1, 2019 at 2pm EST; Full Proposals deadline: July 30, 2019.
    • Transformational Research: Canada 2019. Funding for transformative, novel, high-risk, high-reward translational research projects on neurodegenerative diseases of aging. Amount: $200,000 to $1.5M over up to 3 years.
      Deadlines and INFORMATION WEBINARS are the same as the Rapid Response Canada opportunity listed above.
    • Big Ideas: Canada. Projects must have a significant and sustained impact on translational research to accelerate the development of therapeutics for neurodegenerative diseases of aging, and be led by Canadian Researchers. Amount available: $5M - $20M. Applications are accepted on a rolling basis.
    • Early Phase Clinical Trials: Canada. Projects must involve the development of either a therapeutic, a tool, select complementary approaches, or a combination thereof to help accelerate the development of therapeutics for neurodegenerative diseases of aging. Amount: Up to $1,500,000 per project over up to 4 years. Applications are accepted on a rolling basis.
       
  • Alzheimer's Drug Discovery Foundation (ADDF): Funding Opportunities.  The 2019 deadlines for LOIs are January 18; April 12, July 19, or October 11, 2019.
    • Program to Accelerate Clinical Trials (PACT). This RFP funds early-stage clinical trials through phase 2 for novel drug candidates, proof-of-concept trials in patients for repurposed/repositioned drugs, and regulatory studies for IND/CTA preclinical packages and drug manufacturing for later stage trials. Average amount: Up to USD $5M.
    • Neuroimaging and CSF Biomarker Development. This RFP supports the development and validation of neuroimaging and CSF biomarkers to enhance clinical trials for Alzheimer's disease, related dementias, and cognitive aging. Average amount: USD $150,000-$600,000.
    • Prevention Beyond the Pipeline. This RFP supports comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline. Amount: USD $50,000-$100,000 for epidemiological analyses; USD Up to $3 million for clinical trials.
    • Drug Discovery. This RFP supports programs advancing lead molecules to clinical candidate selection or building preclinical evidence in relevant animal models for repurposed/repositioned drugs. Average amount: USD $150,000-$600,000.
       
  • British Heart Foundation: Big Beat Challenge. The Big Beat Challenge will bring together world-leading researchers and innovators to identify and solve any of the biggest problems in heart and circulatory disease. This initiative will push the international research community to identify a real-world challenge, significant unmet need, or opportunity for game-changing innovation in heart and circulatory science or medicine. The Big Beat Challenge is open to any and all areas of heart and circulatory research, and welcomes applications based anywhere in the world. The Big Beat Challenge is a single research funding award of £30,000,000. Depending on the quality of the applications received, more than one award may be funded in this round of funding. Call will open early January. Deadline for Stage 1 applications: Mid-2019.
     
  • Lupus Research Alliance.
    • Novel Research Grants provide early stage support for highly innovative approaches to major challenges in lupus research. Special emphasis is placed on lupus studies exploring fundamental mechanisms, novel targets and pathways, novel technologies, and interdisciplinary approaches. Early-career investigators are encouraged to apply through this mechanism. Up to USD $150,000 per year for up to two years. Deadline for applications: February 1, 2019.
    • Target Identification in Lupus Grants support highly meritorious research focused on the identification and scientific and/or clinical investigation of molecular pathways and therapeutic targets that will lead to new therapies or improved management for patients with lupus. Up to USD $200,000 per year for up to three years. Deadline for applications: February 1, 2019.
       
  • The Klarman Family Foundation: Eating Disorders Research Grants Program. The fundamental aim of this grants program is to understand the biology underlying the psychiatric disease anorexia nervosa, with the goal of accelerating progress toward prevention and treatment. Grants are funded to academic researchers for 1 – 3 year projects to research the biology of this disease, and the questions of how and why it develops and persists. Approaches that incorporate neurobiology with an up-to-date understanding of the symptoms and dysfunction associated with anorexia nervosa are encouraged. Amount: Up to USD $150,000 for a 1 year pilot study, and up to USD $250,000 per year  for 1 – 3 year research projects (inclusive of up to 10% indirect costs). Deadline for applications: February 14, 2019 at 1pm EST.
     
  • Leukemia Research Foundation: Hollis Brownstein New Investigator Grant 2019. This program funds highly promising scientists in this critical research niche. This program provides a one year grant of USD $100,000 to allow innovative scientists to act on their ideas, and try new procedures and experiments that will lead to significant breakthroughs. Deadline for Letters of Intent: February 1, 2019.
     
  • Organization for Autism Research (OAR): Applied Research Competition. Through this competition, OAR intends to promote evidence-based practices delivered from research in the following areas: 
    The analysis, evaluation, or comparison of current models of assessment, intervention, or systems of service delivery, including policy analysis 
    - Applied aspects of educational, behavioral, or social/communicative intervention 
    - Effective intervention across the lifespan for individuals considered to be severely impacted by autism 
    - Adult issues such as continuing education, employment, residential supports, sexuality instruction, quality-of-life determinants, and "later intervention" 
    - Issues related to family support, social and community integration, assessment and intervention with challenging behavior, and the use of technology in support of learners with ASD 
    Upper amount: USD $40,000. Deadline for preliminary proposals: March 25, 2019.
     
  • Desmoid Tumor Research Foundation (DTRF): Research Grants. The DTRF funds research that will advance the current scientific knowledge about desmoid tumors, moving toward the development of new treatment options and the ultimate goal of a cure. Research proposals with additional sources of funding support are particularly desirable. Researchers must be willing to collaborate with other scientists and institutions with similar interests. Upper amount: USD $65,000. Deadline for applications: April 1, 2019.
     
  • Muscular Dystrophy Association (MDA): Translational Research. MVP funds projects from proof-of-principle studies through phase 2 trials. For-profit entities are required to contribute funds that match or exceed MDA's contribution. MDA will negotiate return on investment. Projects funded by MVP are milestone-driven projects, with funds released according to the completion of pre-agreed upon sections of the project. MVP will consider funding projects up to USD $1M, depending on the stage of research. MVP is interested in partnering with applicants to accelerate research on projects with strong institutional support, and in general MVP funds should constitute less than 50% of the total project budget. Deadline for Letters of Intent: March 1, 2019; June 1, 2019; and September 1, 2019.
     

December 18, 2018
 

  • New Frontiers in Research Fund - Exploration: Convergence Portal now available. Notices of Intent (NOIs) for the NFRF competition are due by 8pm ET on January 11, 2019 using the new Convergence Portal. *The Convergence Portal is now open and available for researchers to create NOIs.
    Information for UofT applicants: An MRA is not required at the NOI stage. If you already have an active login for the NSERC or SSHRC Research Portal you should be able to access the Portal using those same credentials. If you do not have a SSHRC or NSERC portal login, you will need to create a Convergence account. (Note some users with SSHRC or NSERC logins have had to reset their password on the Convergence system.) All proposals from UofT must include the maximum indirect cost rate of 25%. Please note that a budget is not required at the NOI stage. 
  • CIFAR Azrieli Global Scholars Program. The Canadian Institute for Advanced Research (CIFAR ) has announced an opportunity for early career researchers. This initiative invites outstanding early-career researchers to work in collaborative research programs that address some of the most complex challenges facing the world today. The CIFAR Azrieli Global Scholars program provides funding and support to help you build your research network at this early stage in your career. Value: $100,000 in unrestricted research support. Scholars are appointed to a research program, becoming part of a global network of leading researchers pursuing answers to some of the most difficult challenges facing the world today. Applicants must hold a PhD or equivalent degree and be within your first five years of a full-time academic research position. Their research must align with the themes of an eligible CIFAR research program which can be found here. UofT Internal deadline for MRAs: February 1, 2019 at noon. Sponsor deadline: February 5, 2019. Visit the UofT Research Alert.
     
  • Sarcoma Foundation of America (SFA): Research Grants. The SFA has developed a program to provide grants to investigators interested in translational science sarcoma research. Funding is available to cover equipment and supplies in support of research on the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human sarcomas. The SFA will only accept applications that focus on the following areas of research: 
    - Omic characterization of sarcomas and definition of novel targets 
    - Omic patterns of sensitivity and resistance to existing agents 
    - Systemic therapy combinations 
    - Immunotherapy 
    Upper amount: USD $50,000 for one year. Deadline for applications: January 31, 2019.
     
  • FRAXA Research Foundation: Fragile X Syndrome Research Grants.
    • FRAXA Fellowships.  Preference will be given to projects that have a clear practical application and the results of which will be shared in a timely fashion. Any university-based lab in the world may apply. Any scientist is eligible for salary support from these awards (not just postdocs), and a supply budget may be included. Amount: USD $90,000 over two years. Deadline for applications: February 1, 2019.
      Please note
      : It is recommended that potential application send a brief Letter of Intent to Dr. Michael Tranfaglia, MD well in advance of a formal application. 
    •  FRAXA Clinical Trial Grants. These grants are flexible in amount and duration, although smaller amounts will receive preference. Clinical trials must involve human subjects with Fragile X. Highest priority is given to clinical trials of potentially disease-modifying therapeutics which have previously been validated in Fragile X animal models. Applications may be submitted at any time, but a Letter of Intent (LOI) is essential; initial inquiries should be directed to Dr. Michael Tranfaglia at mtranfaglia@fraxa.org.

 

December 12, 2018
 

  • Tri-Agency Fund Competition: New Frontiers in Research Fund (NFRF)- Exploration - inaugural competitionThe NFRF is a flagship initiative of the Tri-Agency (CIHR, NSERC and SSHRC) which will invest $275 million over the next five years, and $65 million ongoing, to support international, interdisciplinary, fast-breaking and high-risk research. It comprises three streams to support ground-breaking research:
    •    Exploration (launched December 2018) will generate opportunities for Canada to build strength in high-risk, high-reward and interdisciplinary research;
    •    Transformation (to be launched in 2019) will provide large-scale support for Canada to build strength and leadership in interdisciplinary and transformative research; and
    •    International (to be launched in 2019) will enhance opportunities for Canadian researchers to participate in research with international partners.
    INAUGURAL COMPETITION
    New Frontiers in Research Fund - Exploration.
    The objective of this inaugural competition is to generate opportunities for early career researchers (ECRs) to conduct high-risk, high-reward and interdisciplinary research not available through funding opportunities currently offered by the three agencies. It seeks to inspire highly innovative projects that defy current research paradigms, propose a unique scientific direction, bring disciplines together beyond the traditional disciplinary approaches, and/or use different perspectives to solve existing problems. Amount: Up to $125,000 per year over 1 or 2 years (includes $25,000/year indirect costs). Frequently asked questions.
    Sponsor deadline for NOIs: January 11, 2018; Sponsor deadline for applications: February 7, 2019.
     
  • Bloorview Research Institute: 2019 Pursuit Award. This prestigious award recognizes outstanding achievements in childhood disability research by PhD students across the globe. Every year, the Pursuit Award receives applications worldwide that are forward-thinking, innovative, and challenge the borders of childhood disability research. Eligibility: Current PhD students (no more than six months away from defence) and postdoctoral trainees/recent graduates (within one year of receiving their PhD) who have made significant contributions in applied or clinical childhood disability research. Any applied or clinical research specifically linked to childhood disability is eligible for consideration. Up to three monetary prizes are awarded and finalists may be eligible for a prestigious post-doctoral fellowship at the Bloorview Research Institute. View the Pursuits Submissions Call 2019. Deadline for applications: February 4, 2019 at 5pm EST.
     
  • MaRS Discovery District: The Opioid Data Challenge. MaRS seeks to engage innovative Canadians — people and organizations of all backgrounds and skills — to propose and test new data sets, sources and methodologies to bolster existing information and better measure opioid overdoses and harms in our communities. Given existing gaps in our understanding of the full scope of the opioid crisis, this challenge is aimed at identifying new data sets, sources and methodologies that will enable quantification of suspected opioid overdoses that fall into these categories. Deadline for Phase 1 - Propose and Develop (up to $10,000): January 23, 2019. Deadline for Phase 2 - Extension (up to $50,000) will be early June 2019.
     
  • Canadian Asthma, Allergy and Immunology Foundation (CAAIF):
    • CAAIF Food Allergy Grant. This grant will provide one grant of $25,000.
    • Aralez Pharmaceuticals Canada Inc. and CAAIF Research Grant in Allergic Rhinitis or Urticaria: This grant will provide one grant of $50,000.
      Deadline for applications: February 18, 2019.
       
  • Spina Bifida and Hydrocephalus Association of Canada (SBHAC): Research Grants. SBHAC would like to invite medical professionals and researchers to apply for a Research Grant based on a project that address the medical issues and treatment of those affected by spina bifida and/or hydrocephalus. Amount: $10,000 - $25,000 for a maximum of 3 years. Deadline for applications: January 31, 2019.
     
  • Burroughs Wellcome Fund (BWF): Innovation in Regulatory Science. The program's focus is on providing support for academic researchers developing new methodologies or innovative approaches in regulatory science that will ultimately inform the regulatory decisions FDA and others make.  This would necessarily draw upon the talents of individuals trained in mathematics, computer science, applied physics, medicine, engineering, toxicology, epidemiology, biostatistics, and systems pharmacology, to name a few. Amount:  Up to $500,000 over five years. Deadline for applications: February 6, 2019.

December 5, 2018
 

  • AGE-WELL Core Research Program (2020-2025) Request for Proposals (RFP). AGE-WELL is Canada’s Technology and Aging Network. The pan-Canadian Network brings together researchers, non-profits, industry, government, care providers, older adults and caregivers to develop technology-based solutions to support healthy aging. As AGE-WELL completes its first five-year mandate (2015-2020), the Network is developing its plans and goals for its next iteration, specifically from 2020-2025. A key aspect of this planning process is the development of AGE-WELL’s next Core Research Program, which is a set of integrated, long-term research projects that are the cornerstone of the Network’s activities. Visit the RFP for the overview of their 8 challenge areas and complete details. AGE-WELL has partnered with Mitacs and MEDTEQ to provide additional funding as part of this RFP. Additional partners and collaborators may join this funding initiative over the coming months. The maximum investment per Core Research Project is $200,000 per year (commencing April 1, 2020) for a minimum of 3 to a maximum of 5 years, for a maximum of $1,000,000 per grant. Deadline for applications: January 4, 2019. Visit the UofT funding opportunity webpage.
    *UPDATE: The UofT internal deadline is December 18, 2018 to accommodate the University's year-end closure. (Draft MRAs to be submitted by the internal deadline)
     
  • Hong Kong University (HKU) - University of Toronto Call for Joint Research Proposals 2018HKU and UofT are contributing matching funds to support collaborative education and research initiatives through a joint call for proposals. To be eligible, a proposal must include team participants from both institutions. Up to two successful proposals will be funded. HKU will provide each approved project up to $100,000 HKD per year to support HKU applicants. U of T will provide each approved project up to $16,000 CAD per year to support U of T applicants. The duration of each project is 12 months. Funding is intended to support research-related mobility expenses, such as costs related to funding travel for the exchange of researchers (students, post-doctoral fellows, research associates and/or PIs) between the institutions. Further details here. Questions should be directed to joanne.chou@utoronto.ca. Deadline for proposals: January 31, 2019.
     
  • International Student Experience Fund (ISEF): Second Impact Grant Competition 2018-2019. The Office of the Vice-President & Provost and the Office of the Vice-President, International are pleased to announce a second Impact Grant competition for the International Student Experience Fund (ISEF) with a deadline of February 1, 2019. 
    Funding Streams: The ISEF supports two streams of activities; Seed ($5,000-$15,000 per year) and Impact ($15,000-$100,000 per year). This two-tiered system is intended to provide opportunities for projects that explore, implement, and scale-up promising practices at different stages of their development and implementation, and create a pathway for projects from their initial inception to their full potential. Both tiers of grants are intended to be completed within 1 to 3 years. Visit their website to read the 2018/19 Thematic Areas. Seed Grants ($5,000-$15,000 per year) can be submitted at any time.
     
  • Physician's Services Inc. (PSI) Foundation: Update/Enhancement to Areas of Non-Support and Resident Research Grants. PSI Foundation is pleased to announce the following enhancements:
    •    PSI is no longer has a separate Mental Health research funding stream offered through a Letter of Intent process. Clinician researchers in the area of mental health are more than welcome to apply to any of their funding opportunities listed on their website (e.g. New Investigator grant). 
    •    The maximum amount of funding per application for Resident Research grants has been raised from $20,000 to $30,000
    Revised funding guidelines are available on their website.
     
  • Mitacs Canadian Science Policy Fellowship - Call for ApplicationsThe Canadian Science Policy Fellowship is now accepting applications from prospective fellows interested in undertaking a 12-month policy position within a Canadian government host office. Eligible applicants must be:
    •    Faculty members at Canadian universities or PhD graduates
    •    Canadian citizens or permanent residents (Citizenship requirements may differ for individual host offices; this will be accommodated in the fellow and host matching process)
    •    Able to negotiate a leave of absence from their university or employer, as applicable
    The 2019 cohort of fellowships will begin September 2019. UofT Internal deadline: January 27, 2019; Sponsor deadline: February 3, 2019.
     
  • UPDATES to NSERC New Research Partnerships Program - Framework and Strategic Partnerships (SPG). Further to information shared with the community about NSERC’s mandate to consolidate its Research Partnerships Programs, NSERC has updated its Framework for the new Partnerships Program. The revised Framework has now been published and is available for review on the NSERC websiteMembers of the research community are invited to review the new Framework and provide their feedback to NSERC.  Individual stakeholders are welcome to reply to RPR@nserc-crsng.gc.ca until January 2, 2019.  We would like to gauge responses from the U of T community and kindly request that a copy of your comments be sent to the Innovations & Partnerships Office via  colin.swift@utoronto.ca. Read more.
     
  • Huntington Society of Canada: Clinical Fellowship Pilot Program 2018. The objective of this program is to increase interest and participation in HD-specific research activities and provide an opportunity for clinicians to pursue future work on HD research projects within Canada. The purpose of this post-residency training is to provide expertise in the diagnosis and management of Huntington disease. Clinical training is the largest component of this hands-on program (at least 80%) but could include an element of research or an HD-specific clinical trial. Amount: $60,000 for one year. Deadline for applications: December 31, 2018.
     
  • (NEW!) Cancer Research Institute: Lloyd J. Old STAR (Scientists TAking Risks) Program. This Program will provide long-term funding to mid-career scientists, providing them a degree of freedom and flexibility to pursue high-risk, high-reward research at the forefront of discovery and innovation. These new grants will not be tied to a specific research project, but rather will support outstanding researchers based on the quality and promise of their overall work. A successful candidate is one that will demonstrate confidence and curiosity to ask difficult immunological questions—forging new understandings and innovation that will drive the field forward. Candidates selected for this award are expected to be future “stars” in the field of cancer immunology. Candidates must hold a tenure-track faculty appointment as an assistant professor (minimum 3 years) or as an associate professor (maximum of 3 years). Amount: USD $1.25 million over five years. Deadline for applications: March 1, 2019.
     
  • Friedreich's Ataxia Research Alliance (FARA):
    • Keith Michael Andrus Cardiac Research Award. Proposals for this award should focus on advancing understanding and/or treatment of the cardiac involvement in FA. Upper amount: USD $150,000 per year for 1 or 2 years. Deadline for Letters of Intent: January 15, 2019.
    • General Research Grants. This Grant is open to qualified investigators proposing projects that fall within FARA Research Priorities. To view lay abstracts of recent FARA-funded General Research Grants, click here. Deadline for Letters of Intent: February 1, 2019.
       
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.

November 28, 2018
 

  • Women's College Research Institute, Women's Xchange: $15K Challenge. The Women's Xchange is offering $15,000 in one-time one year (non-renewable) grants to support research projects that address women’s health issues at the local level. The $15K Challenge is a competitive grant process and only select projects are funded. First time applying for a research grant? Women’s Xchange can provide guidance throughout the application and research process. With access to a Scientific Lead and assistance in developing academic partnerships, applicants will be supported with regards to developing a research proposal and conducting a successful research study. Visit the RFP to view eligibility and further details. Deadline for Notice of Intent: December 7, 2018; Application deadline: January 8, 2019.
     
  • Canadian Blood Services: Blood Efficiency Accelerator Program. The objective of this program is to improve the efficient and appropriate utilization of blood products, while maintaining the safety of the blood system. To achieve this objective, the Program will support innovative research projects that seek new knowledge or accelerate the application of existing knowledge. Maximum amount: $30,000 for one year. Deadline for applications: January 15, 2019.
     
  • Parkinson Canada: Research Grants Program. Pilot Project Grants (including a Targeted Competition: Progressive Supranuclear Palsy (PSP)) / New Investigator Awards / Basic Research Fellowships / Clinical Research Fellowship / Clinical Movement Disorders Fellowships / Graduate Student Awards. Deadline for all applications: February 4, 2019.
     
  • The Kidney Foundation of Canada, Kidney Research Scientist Core Education and National Training (KRESCENT) Program: New Investigator Award. This award to individuals who have clearly demonstrated excellence during their pre-doctoral and post-doctoral training in kidney disease, provides salary support for up to three years of the faculty appointment at the rank of Assistant Professor or its equivalent at a Canadian University. The purpose of this award is to assist such an individual to become established as a fully independent investigator in the field of kidney disease. Preference may be given to candidates who have been awarded and successfully completed a KRESCENT program Post-Doctoral Fellowship or Allied Health Doctoral Scholarship. It is expected that 50% of the award will be contributed by the KRESCENT Program and 50% by the host institution. Deadline for applications: February 1, 2019.
     
  • Leukemia Research Foundation, Hollis Brownstein Research Grants Program: New Investigator Grants. The Foundation is unique in the level of support it provides to highly promising scientists in this absolutely critical research niche. Providing one year grants of USD $100,000 for one year to selected New Investigator researchers, allows innovative scientists to act on their ideas, and try new procedures and experiments that will hopefully lead to significant breakthroughs. New Investigators are considered to be within seven (7) years of their first independent position. Preference will be given to proposals that focus on leukemia, lymphoma, MDS, and multiple myeloma. Deadline for Letters of Intent: February 1, 2019.
     
  • Alex's Lemonade Stand Foundation. Pediatric Cancer Research Grants.
    • Young Investigator Grants. Demonstration of outstanding mentorship and demonstration of a career plan that shows commitment to pediatric cancer investigation are critical components of a successful application. Upper amount: USD $150,000 over three years. Application deadline: December 17, 2018.
    • Epidemiology Grants. These grants support investigators to pursuing research studies in human populations, using epidemiological approaches, in order to significantly contribute to the understanding of childhood cancers. Hypothesis-driven research may focus on risk factors, early detection, prevention, effectiveness and treatment outcomes. Upper amount: USD $100,000 over two years. Application deadline: December 17, 2018.
       
  • US Dept. of Defense, CDMRP: Amyotrophic Lateral Sclerosis Research Program (ALSRP). 
    • Therapeutic Development Award. This award supports research ranging from validation of therapeutic leads through U.S. Food and Drug Administration (FDA) Investigational New Drug (IND)-enabling studies. The proposed studies are expected to be empirical in nature and product driven. Upper amount: USD $1,000,000 over two years. Deadline for pre-applications: March 22, 2019.
    • Therapeutic Idea Award. The award is designed to promote new ideas aimed at drug or treatment discovery that are still in the early stages of development. Projects that focus primarily on investigating the pathophysiology of ALS are not within the scope of this Funding Opportunity. Innovation and impact are important aspects of the Therapeutic Idea Award. Deadline for pre-applications: March 22, 2019.
       
  • NIH Various Opportunities. The National Institutes of Health has recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
  • National Psoriasis Foundation (NPF): Research Grants Program.
    • Discovery Grants. Discovery Grants fund researchers while they explore preliminary ideas and conduct proof-of-concept experiments. Applications related to all aspects of psoriatic disease are strongly encouraged, including basic science, translational research, technology, epidemiology, health services, and clinical research. Applicants may request up to USD $75,000 per year. Deadline for applications: January 19, 2018.
    • Translational Research Grants. Translational Research Grants fund research initiatives that focus on the rapid translation of basic scientific discoveries into clinical applications with a clear benefit for patients with psoriatic disease. Applicants may request up to USD $100,000 per year. Deadline for applications: January 19, 2018.
    • Psoriatic Arthritis Research Grant. In a collaborative effort, the Arthritis National Research Foundation (ANRF) and the National Psoriasis Foundation (NPF) are seeking grant applications that focus on studying psoriatic arthritis. Applicants may request up to USD $100,000 per year. Deadline for applications: January 19, 2018.
    • Psoriatic Arthritis Diagnostic Test Grant. Through this exciting new program, NPF is seeking applicants to submit grants that aim to develop a clinically applicable diagnostic test for psoriatic arthritis within five years. Awards are up to USD $100,000 in year 1 for proof-of-concept studies with the possibility of renewal at up to $300,000 annually in subsequent years (five years total). Deadline for LOIs: December 14, 2018.
    • Early Career Research Grants. The NPF is seeking grant applications from graduate students, postdoctoral researchers, and researchers at similar trainee-level positions interested in conducting projects focused on psoriatic disease. Deadline for applications: January 19, 2018.

 

 

Back to Top